Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32983
Title: | Effect of Intensity of Home Noninvasive Ventilation in Individuals With Neuromuscular and Chest Wall Disorders: A Systematic Review and Meta-Analysis of Individual Participant Data. | Austin Authors: | Delorme, Mathieu;Leotard, Antoine;Lebret, Marius;Lefeuvre, Claire;Hazenberg, Anda;Pallero, Mercedes;Nickol, Annabel H;Hannan, Liam M ;Boentert, Matthias;Yüksel, Aycan;Windisch, Wolfram;Howard, Mark E ;Hart, Nicholas;Wijkstra, Peter J;Prigent, Hélène;Pepin, Jean-Louis;Lofaso, Frederic;Khouri, Charles;Borel, Jean-Christian | Affiliation: | Université Paris-Saclay, UVSQ, ERPHAN, 78000 Versailles, France Service de Physiologie et explorations fonctionnelles, GHU APHP - Paris Saclay - Hôpital Raymond Poincaré (APHP), 92380 Garches, France University of Groningen, University Medical Center Groningen, GRIAC Research Institute, The Netherlands. Neurology Department, Raymond Poincaré University Hospital, Garches, APHP, France University of Groningen, University Medical Center Groningen, Department of Pulmonology and Tuberculosis, Department of Home Mechanical Ventilation, Groningen, The Netherlands Respiratory Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain Oxford Centre for Respiratory Medicine, Oxford University Hospital NHS Foundation Trust, Oxford OX3 7LE, UK Department of Respiratory Medicine, Northern Health, Melbourne, Victoria, Australia Department of Neurology, Münster University Hospital (UKM), Münster, Germany Ufuk University, Faculty of Medicine, Rıdvan Ege Hospital, Department of Pulmonology and Tuberculosis, Ankara, Turkey. Cologne Merheim Hospital, Department of Pneumology, Kliniken der Stadt Köln, gGmbH, Witten/Herdecke University, Germany. Institute for Breathing and Sleep Lane Fox Clinical Respiratory Physiology Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK HP2 (Hypoxia and Physio-Pathologies) Laboratory, Inserm (French National Institute of Health and Medical Research) U1300, University Grenoble Alpes, Grenoble, France Research and Development Department, AGIR à dom Association, 36 Bd du Vieux Chêne, 38240 Meylan, France. Centre Régional de pharmacovigilance, Centre d'Investigation Clinique, CHU Grenoble Alpes, France. Nord-Est-Ile-de-France Neuromuscular Reference Center, FHU PHENIX, France. AFM-Téléthon, Direction des Actions Médicales, 91000 Evry, France CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. The Royal Brompton Hospital, London SW3 6NP, UK. Dept of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia. Department of Medicine, UKM-Marienhospital Steinfurt, Steinfurt, Germany. Turner Institute for Brain and Mental Health, Monash University, Melbourne, Australia. Centre for Human and Applied Physiological Science, King's College London, London, UK. FHU Phenix - GHU APHP - Paris Saclay - Hôpital Raymond Poincaré (APHP), 92380 Garches, France. EFCR (Cardiovascular and Respiratory Function) Laboratory, Grenoble Alpes University Hospital, Grenoble, France. |
Issue Date: | Aug-2023 | Date: | 2023-05 | Publication information: | Archivos de Bronconeumologia 2023-08; 59(8) | Abstract: | Home noninvasive ventilation (NIV), targeting a reduction of carbon dioxide with a combination of sufficient inspiratory support and backup-rate improves outcomes in patients with chronic obstructive pulmonary disease. The aim of this systematic review with individual participant data (IPD) meta-analysis was to evaluate the effects of intensity of home NIV on respiratory outcomes in individuals with slowly progressive neuromuscular (NMD) or chest-wall disorders (CWD). Controlled, non-controlled and cohort studies indexed between January-2000 and December-2020 were sought from Medline, Embase and the Cochrane Central Register. Outcomes were diurnal PaCO2, PaO2, daily NIV usage, and interface type (PROSPERO-CRD 42021245121). NIV intensity was defined according to the Z-score of the product of pressure support (or tidal volume) and backup-rate. 16 eligible studies were identified; we obtained IPD for 7 studies (176 participants: 113-NMD; 63-CWD). The reduction in PaCO2 was greater with higher baseline PaCO2. NIV intensity per se was not associated with improved PaCO2 except in individuals with CWD and the most severe baseline hypercapnia. Similar results were found for PaO2. Daily NIV usage was associated with improvement in gas exchange but not with NIV intensity. No association between NIV intensity and interface type was found. Following home NIV initiation in NMD or CWD patients, no relationship was observed between NIV intensity and PaCO2, except in individuals with the most severe CWD. The amount of daily NIV usage, rather than intensity, is key to improving hypoventilation in this population during the first few months after introduction of therapy. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/32983 | DOI: | 10.1016/j.arbres.2023.05.002 | ORCID: | Journal: | Archivos de Bronconeumologia | PubMed URL: | 37217384 | ISSN: | 1579-2129 | Type: | Journal Article | Subjects: | Chest wall disorders Meta-analysis Neuromuscular diseases Noninvasive ventilation Systematic review |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.